Changing Physical Activity Behavior in Individuals With Type 2 Diabetes Using Counceling and Information From Continuous Glucose Monitoring
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00542698|
Recruitment Status : Completed
First Posted : October 11, 2007
Last Update Posted : October 11, 2007
|Condition or disease||Intervention/treatment||Phase|
|Type 2 Diabetes Mellitus||Behavioral: Effect of Physical Activity on Type II Diabetes Mellitus||Phase 1|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||52 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Changing Activity Behavior With Glucose Sensor Feedback|
|Study Start Date :||July 2004|
|Actual Study Completion Date :||December 2005|
No Intervention: Control
Control group uses 90 minutes of standard diabetes education/ 7 days using the International Diabetes Center curriculum & update phone call at 4 weeks.
Interventional group received standard diabetes education, CGMS monitor, and extra educational topics including CGMS counceling.
Behavioral: Effect of Physical Activity on Type II Diabetes Mellitus
Reviewing participants and a role model's continuous glucose monitor graphs, discussing benefits of physical activity and setting physical activity goals.
- increased physical activity [ Time Frame: 8 Weeks ]
- BP, BMI, & HgA1c (a long term measure of blood glucose) [ Time Frame: 8 Weeks ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00542698
|United States, Massachusetts|
|Berkshire Health System|
|Pittsfield, Massachusetts, United States, 01201|
|Baystate Health System|
|Springfield, Massachusetts, United States, 01199|
|Principal Investigator:||Nancy A Allen, Ph.D.||University of Massachusetts Worcester Medical School|